LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation

LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. A J Jenkins , R L Klein , C N Chassereau , K L Hermayer and M F Lopes-Virella Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA. Abstract Increased susceptib...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 45; no. 6; pp. 762 - 767
Main Authors Jenkins, A. J., Klein, R. L., Chassereau, C. N., Hermayer, K. L., Lopes-Virella, M. F.
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.06.1996
Online AccessGet full text
ISSN0012-1797
1939-327X
0012-1797
DOI10.2337/diabetes.45.6.762

Cover

Loading…
Abstract LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. A J Jenkins , R L Klein , C N Chassereau , K L Hermayer and M F Lopes-Virella Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA. Abstract Increased susceptibility of LDL to oxidation has been shown to be associated with the presence of coronary heart disease and may account for the accelerated vascular disease seen in diabetes. The response of LDL to in vitro oxidative stress has been proposed as a measure of the predisposition of LDL to the in vivo subendothelial oxidative stress. Increased susceptibility to oxidation has been demonstrated recently in diabetic patients with poorly controlled IDDM. Thus, we conducted studies to determine whether the increased susceptibility of LDL to oxidation was secondary to diabetes per se or to the level of glycemic control. Fifteen IDDM patients with good glycemic control and with no evidence of macrovascular disease or proteinuria were compared with healthy age-, sex-, race-, and BMI-matched nondiabetic subjects. Fasting blood glucose levels averaged 12.1 +/- 1.1 (mean +/- SE) vs. 4.9 +/- 0.1 mmol/l in the diabetic versus the control groups, respectively. HbA1c levels averaged 7.7 +/- 0.5 vs. 4.4 +/- 0.2%, reflecting well-controlled diabetes (P < 0.0001). Total, LDL, VLDL, and HDL cholesterol, triglyceride, and lipoprotein(a) levels did not differ between the groups. The particle size, lipid composition, fatty acid content, antioxidant content, and glycation were similar for LDL isolated from both groups. A rapid LDL preparation technique was used to compare LDL susceptibility to oxidation under the following conditions: final LDL cholesterol concentration of 100 microg/ml, 5 micromol/l of CuCl2 at 25 degrees C. There was no difference in the susceptibility to in vitro oxidation of LDL isolated from IDDM patients compared with control subjects. There was no correlation of glycemic control with any of the parameters of the in vitro oxidation of LDL. LDL from patients with well-controlled IDDM does not differ in composition or in susceptibility to in vitro oxidative stress compared with LDL from nondiabetic subjects.
AbstractList Abstract only
LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. A J Jenkins , R L Klein , C N Chassereau , K L Hermayer and M F Lopes-Virella Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA. Abstract Increased susceptibility of LDL to oxidation has been shown to be associated with the presence of coronary heart disease and may account for the accelerated vascular disease seen in diabetes. The response of LDL to in vitro oxidative stress has been proposed as a measure of the predisposition of LDL to the in vivo subendothelial oxidative stress. Increased susceptibility to oxidation has been demonstrated recently in diabetic patients with poorly controlled IDDM. Thus, we conducted studies to determine whether the increased susceptibility of LDL to oxidation was secondary to diabetes per se or to the level of glycemic control. Fifteen IDDM patients with good glycemic control and with no evidence of macrovascular disease or proteinuria were compared with healthy age-, sex-, race-, and BMI-matched nondiabetic subjects. Fasting blood glucose levels averaged 12.1 +/- 1.1 (mean +/- SE) vs. 4.9 +/- 0.1 mmol/l in the diabetic versus the control groups, respectively. HbA1c levels averaged 7.7 +/- 0.5 vs. 4.4 +/- 0.2%, reflecting well-controlled diabetes (P < 0.0001). Total, LDL, VLDL, and HDL cholesterol, triglyceride, and lipoprotein(a) levels did not differ between the groups. The particle size, lipid composition, fatty acid content, antioxidant content, and glycation were similar for LDL isolated from both groups. A rapid LDL preparation technique was used to compare LDL susceptibility to oxidation under the following conditions: final LDL cholesterol concentration of 100 microg/ml, 5 micromol/l of CuCl2 at 25 degrees C. There was no difference in the susceptibility to in vitro oxidation of LDL isolated from IDDM patients compared with control subjects. There was no correlation of glycemic control with any of the parameters of the in vitro oxidation of LDL. LDL from patients with well-controlled IDDM does not differ in composition or in susceptibility to in vitro oxidative stress compared with LDL from nondiabetic subjects.
Author M F Lopes-Virella
K L Hermayer
A J Jenkins
C N Chassereau
R L Klein
Author_xml – sequence: 1
  givenname: A. J.
  surname: Jenkins
  fullname: Jenkins, A. J.
– sequence: 2
  givenname: R. L.
  surname: Klein
  fullname: Klein, R. L.
– sequence: 3
  givenname: C. N.
  surname: Chassereau
  fullname: Chassereau, C. N.
– sequence: 4
  givenname: K. L.
  surname: Hermayer
  fullname: Hermayer, K. L.
– sequence: 5
  givenname: M. F.
  surname: Lopes-Virella
  fullname: Lopes-Virella, M. F.
BookMark eNp9kEtLAzEUhYNUalv9Ae6yFmbMYyaZWUrrozDiRkFXQyYPG0knJYlW_72jVQQFuYuz-b7D5UzBqPe9BuAYo5xQyk-VFZ1OOuZFmbOcM7IHJrimdUYJvx-BCUKYZJjX_ABMY3xCCLHhxmBcMVqyEk3AQ7NooAl-DTciWd2nCLc2reBWO5dJ36fgndMKLheLa2gj7H2Cax80jM9R6k2yndMweWh7-GIHGPpXq4Ym3x-CfSNc1EdfOQN3F-e386usublczs-aTBKMUqaxEIqbQglSs45qgbuSmK420iiilDCyKlVlhMaSGMo4K4jgApmKl2rAGZ0BvOuVwccYtGk3wa5FeGsxaj9War9XaouyZe2w0uDwX4606fPrFIR1_5onO3NlH1dbG_QP8xd-B_Jbgg8
CitedBy_id crossref_primary_10_5352_JLS_2007_17_11_1571
crossref_primary_10_1016_S0261_5614_98_80015_0
crossref_primary_10_2337_diacare_26_3_810
crossref_primary_10_1089_15209150050502014
crossref_primary_10_1002_dmrr_231
crossref_primary_10_1016_S0953_6205_99_00009_6
crossref_primary_10_1016_j_metabol_2004_01_002
crossref_primary_10_1016_j_metabol_2006_05_012
crossref_primary_10_1111_j_1582_4934_2007_00068_x
crossref_primary_10_1016_S0891_5849_97_00213_X
crossref_primary_10_2337_diabetes_54_1_1
crossref_primary_10_1016_j_metabol_2004_10_012
crossref_primary_10_1111_j_1582_4934_2002_tb00456_x
crossref_primary_10_1111_j_1464_5491_2006_01905_x
crossref_primary_10_1002_dmrr_491
crossref_primary_10_1016_S0021_9150_00_00534_7
crossref_primary_10_1016_S0021_9150_97_00320_1
crossref_primary_10_1046_j_1464_5491_1999_00191_x
crossref_primary_10_1016_S0026_0495_99_90237_8
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.2337/diabetes.45.6.762
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
0012-1797
EndPage 767
ExternalDocumentID 10_2337_diabetes_45_6_762
diabetes_45_6_762
GroupedDBID -
08R
0R
29F
53G
55
5GY
5RE
5RS
8F7
8GL
AAQQT
AAWTL
AAYEP
AAYJJ
ABFLS
ABOCM
ABPTK
ACGOD
ACPRK
ADBIT
AENEX
AFFNX
AHMBA
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DU5
EBS
F5P
FRP
GICCO
GJ
GX1
H13
HZ
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
J5H
KM
L7B
M5
MVM
O9-
OB3
OBH
OVD
P2P
RHF
RHI
RPM
SJN
SV3
TDI
VH1
WH7
WOW
X7M
XZ
YQJ
ZA5
ZGI
ZXP
ZY1
---
.55
.GJ
.XZ
08P
0R~
1CY
354
6PF
AAFWJ
AAYXX
ACGFO
AEGXH
AERZD
AI.
AIAGR
AIZAD
ALIPV
CITATION
EMOBN
HZ~
ITC
M5~
N4W
OHH
OK1
TEORI
VVN
YFH
YOC
~KM
ID FETCH-LOGICAL-c210t-e1aad7f4da296b3ea1b52fb9fcfd2ddafc85d8fae1c2f367642a7a0f875db3e63
ISSN 0012-1797
IngestDate Thu Apr 24 22:54:17 EDT 2025
Tue Jul 01 03:03:52 EDT 2025
Fri Jan 15 19:48:14 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c210t-e1aad7f4da296b3ea1b52fb9fcfd2ddafc85d8fae1c2f367642a7a0f875db3e63
PMID 8635650
PageCount 6
ParticipantIDs crossref_primary_10_2337_diabetes_45_6_762
highwire_diabetes_diabetes_45_6_762
crossref_citationtrail_10_2337_diabetes_45_6_762
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 1900
PublicationDate 19960601
1996-06-01
PublicationDateYYYYMMDD 1996-06-01
PublicationDate_xml – month: 06
  year: 1996
  text: 19960601
  day: 01
PublicationDecade 1990
PublicationTitle Diabetes (New York, N.Y.)
PublicationYear 1996
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
SSID ssj0006060
Score 1.7247286
Snippet LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. A J Jenkins , R L Klein , C N Chassereau , K L Hermayer and M F...
Abstract only
SourceID crossref
highwire
SourceType Enrichment Source
Index Database
Publisher
StartPage 762
Title LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation
URI http://diabetes.diabetesjournals.org/content/45/6/762.abstract
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqISFe0LiJbYAswRNRQuI4Sfc4LaCttDygTRpPkR3bIlKVIpoi4H_wf3dO4jihK4jxEjWufdTmfDq3nAshrwRgiKksBumnlM-NDH1QgnAbcykY16U0GBpYfEjPLvnsKrmaTH6NspY2jQzKnzvrSv6Hq7AGfMUq2Vtw1hGFBfgM_IUrcBiu_8TjeT7v6kNsd1RbqobxON_moC_BoDzP8wUOLq9XjYd5td56s26zWbBqCmzPqva-VbDZW32v1MApa7Lmo-js9tyeURxhpnEIQzfbOPBmgZPkSztO82Pgzd3q6WeBeQBabNpIbQDUhqgs6IofNtfDnVG2Ui8dEqh6YRsx7H7a6VO9Y80K4K6fpAXaWJr2glrbu2yXzGdx2zWgD1UHPAnSwJ0c99fe0nsuGxH8ICRS9CQKnhRpkaFmv8PA-8CJIPn5e6fgwefrKpvsf-leliOJNzd-xe_mTt-CemTCXOyT-9b3oCcdkB6Qia4fkrsLm13xiHwCPFHEE-3xRBFPdAtPFPFEqzUFPFHEEx3hiTYrWtW0xRN1eHpMLt-9vTg98-3oDb9kUdj4OhJCZYYrwY5TGWsRyYQZeWxKo5hSwpTTRE2N0FHJDDb940xkIjTg_SrYnsZPyF69qvVTQhNtjAHNUWYs4jqeChyUmxkDnonK0lAekLB_QkVp-9LjeJRl8Ue-HJDX7siXrinL3za_7B_78OWNXYe3IXlE7g2Af0b2mq8b_Rxs00a-aJFyDXmmkHk
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LDL+from+patients+with+well-controlled+IDDM+is+not+more+susceptible+to+in+vitro+oxidation&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Jenkins%2C+A.+J.&rft.au=Klein%2C+R.+L.&rft.au=Chassereau%2C+C.+N.&rft.au=Hermayer%2C+K.+L.&rft.date=1996-06-01&rft.issn=0012-1797&rft.eissn=0012-1797&rft.volume=45&rft.issue=6&rft.spage=762&rft.epage=767&rft_id=info:doi/10.2337%2Fdiabetes.45.6.762&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_diabetes_45_6_762
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon